RCUS
Arcus Biosciences Inc
26.40$
-1.8%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | 184.9% | 594.3% | 523.2% | 203.8% | 1.8% | 12.5% | 290.6% | 3.9% | 4.0% | |
| – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 96.0% | |
| – | 3,341.7% | 594.3% | 523.2% | 203.8% | 67.1% | 257.1% | 290.6% | 173.6% | 211.7% | |
| – | 540.4% | 162.4% | 168.2% | 55.1% | 18.8% | 92.9% | 100.0% | 46.5% | 44.5% | |
| – | 3,882.1% | 756.8% | 691.4% | 259.0% | 85.9% | 350.0% | 390.6% | 227.9% | 252.2% | |
| – | -3,782.1% | -656.8% | -591.4% | -159.0% | 14.1% | -250.0% | -290.6% | -127.9% | -156.3% | |
| – | 0.0% | 58.9% | 0.0% | 0.0% | 0.1% | 1.8% | 1.7% | 1.6% | 3.2% | |
| – | -3,756.7% | -593.7% | -564.7% | -157.7% | 14.4% | -237.5% | -257.3% | -109.7% | -142.9% | |
| – | 0.0% | 63.0% | -58.5% | -7.9% | 0.5% | 0.9% | 5.1% | 0.4% | – | |
| – | -3,756.7% | -593.7% | -506.2% | -157.7% | 13.8% | -238.4% | -262.4% | -109.7% | -142.9% | |
| – | -3,597.2% | -612.9% | -567.5% | -153.8% | 15.4% | -230.4% | -248.7% | -104.3% | -135.6% |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.